Chroma Therapeutics Ltd
Patent Applications and Registrations
Patent applications and USPTO patent grants for Chroma Therapeutics Ltd.The latest application filed is for "2-aminopyrazine derivatives as csf-1 r kinase inhibitors".
Company Profile
0.23.33
- Chroma Therapeutics Ltd - Abingdon, Oxfordshire N/A GB
- Chroma Therapeutics Ltd - Abingdon GB
- Chroma Therapeutics Ltd. - Abingdon Oxfordshire GB
- CHROMA THERAPEUTICS LTD. - GB GB
- Chroma Therapeutics Ltd. - Abingdon, Oxfordshire GB
- Chroma Therapeutics Ltd. - Oxfordshire GB
- Chroma Therapeutics Ltd - Oxfordshire GB
- Chroma Therapeutics Limited - Oxfordshire GB
- Chroma Therapeutics Ltd. -
- CHROMA THERAPEUTICS LTD. - OXFORDHSIRE GB
- CHROMA THERAPEUTICS LTD. - Abingdon, Oxford GB
- Chroma Therapeutics Limited - Oxfordshir GB 0X14 4RY
- Chroma Therapeutics Limited - London GB
Patent Activity
| Patent | Date |
|---|---|
| Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]- -3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof Grant 9,896,417 - Pintat , et al. February 20, 2 | 2018-02-20 |
| 2-aminopyrazine Derivatives As Csf-1 R Kinase Inhibitors App 20170157118 - Davies; Stephen John ; et al. | 2017-06-08 |
| 2-aminopyrazine derivatives as CSF-1R kinase inhibitors Grant 9,604,940 - Davies , et al. March 28, 2 | 2017-03-28 |
| Tert-butyl N-[2-ethyl]-l-alaninate Or A Salt,hydrate Or Solvate Thereof App 20160297760 - Pintat; Stephane ; et al. | 2016-10-13 |
| Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]- -3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof Grant 9,388,136 - Pintat , et al. July 12, 2 | 2016-07-12 |
| Benzamide Derivatives And Their Use As Hsp90 Inhibtors App 20160193200 - Donald; Alastair David Graham ; et al. | 2016-07-07 |
| Benzamide derivatives and their use as HSP90 inhibtors Grant 9,321,718 - Donald , et al. April 26, 2 | 2016-04-26 |
| 2-aminopyrazine Derivatives As Csf-1 R Kinase Inhibitors App 20150368210 - Davies; Stephen John ; et al. | 2015-12-24 |
| Enzyme inhibitors Grant 9,133,104 - Davidson , et al. September 15, 2 | 2015-09-15 |
| Tert-butyl N-[2-ethyl]-l-alaninate Or A Salt, Hydrate Or Solvate Thereof App 20150246883 - Pintat; Stephane ; et al. | 2015-09-03 |
| Enzyme And Receptor Modulation App 20150126534 - Davidson; Alan Hornsby ; et al. | 2015-05-07 |
| Inhibitors of P38 map kinase Grant 8,778,953 - Moffat , et al. July 15, 2 | 2014-07-15 |
| Enzyme Inhibitors App 20140163042 - Davidson; Alan Hornsby ; et al. | 2014-06-12 |
| Enzyme Inhibitors App 20140155439 - Donald; Alastair David Graham ; et al. | 2014-06-05 |
| Enzyme inhibitors Grant 8,686,032 - Davidson , et al. April 1, 2 | 2014-04-01 |
| Enzyme And Receptor Modulation App 20140088159 - Drummond; Alan Hastings ; et al. | 2014-03-27 |
| Compounds which inhibit members of the histone deacetylase family of enzymes and their use in the treatment of cell proliferative diseases Grant 8,637,547 - Davidson , et al. January 28, 2 | 2014-01-28 |
| Imaging Agents App 20140010762 - Charlton; Michael Hugh ; et al. | 2014-01-09 |
| Enzyme Inhibitors App 20130116318 - Davidson; Alan Hornsby ; et al. | 2013-05-09 |
| Adenine derivative as inhibitors of HSP90 for the treatment of cancer Grant 8,217,050 - Moffat , et al. July 10, 2 | 2012-07-10 |
| DHFR enzyme inhibitors Grant 8,211,900 - Davidson July 3, 2 | 2012-07-03 |
| Enzyme Inhibitors App 20120149736 - Donald; Alastair David Graham ; et al. | 2012-06-14 |
| Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity Grant 8,148,531 - Davidson , et al. April 3, 2 | 2012-04-03 |
| Inhibitors of IKK-beta serine-threonine protein kinase Grant 8,106,091 - Moffat , et al. January 31, 2 | 2012-01-31 |
| P38 MAP kinase inhibitors Grant 8,044,211 - Moffat , et al. October 25, 2 | 2011-10-25 |
| IKK-beta serine-threonine protein kinase inhibitors Grant 8,003,695 - Moffat , et al. August 23, 2 | 2011-08-23 |
| Inhibitors of PLK App 20110190306 - Moffat; David Festus Charles ; et al. | 2011-08-04 |
| Hydroxamic acid derivatives as inhibitors of HDAC enzymatic activity Grant 7,973,181 - Davidson , et al. July 5, 2 | 2011-07-05 |
| Enzyme inhibitors Grant 7,939,666 - Davidson , et al. May 10, 2 | 2011-05-10 |
| Histone deacetylase inhibitors Grant 7,932,246 - Moffat , et al. April 26, 2 | 2011-04-26 |
| Substituted Thiopenecarboxamides As Ikk-beta Serine-, Threonine-protein Kinase Inhibitors App 20110046210 - Moffat; David Festus Charles ; et al. | 2011-02-24 |
| Inhibitors Of Ikk-beta Serine-theronine Protein Kinase App 20110039920 - Moffat; David Festus Charles ; et al. | 2011-02-17 |
| Hydroxamates As Inhibitors Of Histone Deacetylase App 20100317678 - Moffat; David Festus Charles ; et al. | 2010-12-16 |
| P38 Map Kinase Inhibitors App 20100267774 - Moffat; David Festus Charles ; et al. | 2010-10-21 |
| Pteridine Derivatives As Polo-like Kinase Inhibitors Useful In The Treatment Of Cancer App 20100216802 - Moffat; David Festus Charles ; et al. | 2010-08-26 |
| Histone Deacetylase Inhibitors App 20100152155 - Moffat; David Festus Charles ; et al. | 2010-06-17 |
| Inhibitors Of IKK-Beta Serine-Threonine Protein Kinase App 20100069473 - Moffat; David Festus Charles ; et al. | 2010-03-18 |
| Adenine Derivative As Inhibitors Of Hsp90 For The Treatment Of Cancer App 20100035901 - Moffat; David Festus Charles ; et al. | 2010-02-11 |
| Hdac Inhibitors App 20100010010 - Davidson; Alan Hornsby ; et al. | 2010-01-14 |
| Thiazole Derivatives As Inhibitors Of P13 Kinase App 20100010057 - Moffat; David Charles Festus ; et al. | 2010-01-14 |
| Pteridine Derivatives As Polo-like Kinase Inhibitors Useful In The Treatment Of Cancer App 20100004250 - Philips; Oliver James ; et al. | 2010-01-07 |
| Hydroxamic Acid Derivatives As Inhibitors Of Hdac Enzymatic Activity App 20090298924 - Davidson; Alan Hornsby ; et al. | 2009-12-03 |
| Enzyme Inhibitors App 20090291978 - Davidson; Alan Hornsby ; et al. | 2009-11-26 |
| Enzyme and Receptor Modulation App 20090215800 - Davidson; Alan Hornsby ; et al. | 2009-08-27 |
| Inhibitors of P38 Map Kinase App 20090203711 - Moffat; David Charles Festus | 2009-08-13 |
| Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity App 20090131461 - Davidson; Alan Hornsby ; et al. | 2009-05-21 |
| P38 Map Kinase Inhibitors App 20090099185 - Moffat; David Charles Festus ; et al. | 2009-04-16 |
| Carboline and betacarboline derivatives for use as hdac enzyme inhibitors App 20060235012 - Davidson; Alan Hornsby ; et al. | 2006-10-19 |
| Methods and means of histone methylation Grant 7,074,578 - Kouzarides , et al. July 11, 2 | 2006-07-11 |
| Assays, methods and means for modulating e2f activity Grant 6,890,709 - Kouzarides May 10, 2 | 2005-05-10 |
| Assays, methods and means for modulating nuclear localization Grant 6,747,005 - Kouzarides June 8, 2 | 2004-06-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 